Nuzenio

European Biotechnology Magazine

European Biotechnology Magazine entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 8 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Clinical Development Expert has started - European Biotechnology MagazineEuropean Biotechnology Magazine · Fri, 07 Aug 2026 09:27:17 GMT Actimed retrieves ALS drug after Faraday collapse - European Biotechnology MagazineEuropean Biotechnology Magazine · Thu, 06 Aug 2026 12:13:31 GMT Evexta pairs ex-Merck drug with Roche’s giredestrant - European Biotechnology MagazineEuropean Biotechnology Magazine · Wed, 05 Aug 2026 08:30:00 GMT Ipsen quietly returns cancer drug IPN01194 to AGV Discovery - European Biotechnology MagazineEuropean Biotechnology Magazine · Mon, 03 Aug 2026 15:51:30 GMT Sobi’s dealmaker CEO exits for BioNTech - European Biotechnology MagazineEuropean Biotechnology Magazine · Mon, 03 Aug 2026 10:10:00 GMT AstraZeneca explores $400B combination with BMS - European Biotechnology MagazineEuropean Biotechnology Magazine · Mon, 03 Aug 2026 08:54:08 GMT ZEUS failure clouds future of Novo’s cardiovascular plans - European Biotechnology MagazineEuropean Biotechnology Magazine · Fri, 31 Jul 2026 16:28:08 GMT Relation deepens GSK alliance with $110M deal - European Biotechnology MagazineEuropean Biotechnology Magazine · Thu, 30 Jul 2026 11:12:13 GMT

Timeline

Fri, 07 Aug 2026 09:27:17 GMTClinical Development Expert has started - European Biotechnology Magazine

Thu, 06 Aug 2026 12:13:31 GMTActimed retrieves ALS drug after Faraday collapse - European Biotechnology Magazine

Wed, 05 Aug 2026 08:30:00 GMTEvexta pairs ex-Merck drug with Roche’s giredestrant - European Biotechnology Magazine

Mon, 03 Aug 2026 15:51:30 GMTIpsen quietly returns cancer drug IPN01194 to AGV Discovery - European Biotechnology Magazine

Mon, 03 Aug 2026 10:10:00 GMTSobi’s dealmaker CEO exits for BioNTech - European Biotechnology Magazine

Mon, 03 Aug 2026 08:54:08 GMTAstraZeneca explores $400B combination with BMS - European Biotechnology Magazine

Related explainers

HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.

Connected entities

Clinical Development Expert2 live mentions Actimed2 live mentions ALS2 live mentions Faraday2 live mentions Evexta2 live mentions Merck2 live mentions Roche2 live mentions Ipsen2 live mentions Sobi2 live mentions CEO2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for European Biotechnology Magazine.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.